» Download Public Reports
78 reports
- Industry report
- June 2013
- 15 pages
... The tenofovir gel arm 6 Month treatment success rate 88.9% 12 Summary Caprisa 008 provides an opportunity to generate evidence for implementation that will be required when a licensed product ...
April 2013
... Equity of access on paper but weak 1010 20/04/2013 harm reduction as a policy pillar is: Rejected by nigeria; Included in 2012-16 drug master plan of so africa but defined as achieved through treatment ...
March 2013
... Care consumers and patientsinsurance and risk carriers consumer demand demand for medicines key questions: Does household making on care seeking and treatment differ by gender Can ...
March 2013
... Income public market only case of malaria vaccine indicated for use only in malaria-endemic populations Lengthy, costly process to determine if a vaccine works in children; no correlate of protection ...
February 2013
... vaccines) Reserve: rolling stock Bank: bulk and/or ready to use : to ensure product availability and rapid response in case of threat of outbreaks vaccines against diseases that can have ...
February 2013
... Diagnostics Cost constraints Limited am surveillance & monitoring Widespread sale of counterfeit, fake, low potency products (vaccines and chemotherapeutics) Favours resistance development ...
November 2012
... Of medicines: Support to individual countries upon demand (e.G. China; india; viet nam etc.(; Regional (multi-country( collaboration programmes: 1. Eu/who/african countries (15( for health related mdgs ...
October 2012
... Drugs (cocaine, heroin, methamphetamine, cannabis, others) o counterfeit goods (including all ip violations ) And medicine o human beings (tip and som) o firearms (or all weaponry ) O natural ...
October 2012
... Model repeated measures analysis wallis et al., Aids 2012 tackling tb through technology discovery and development process the context: approach to tb drug/regimen development drug candi date pool ...